Form 8-K RIGEL PHARMACEUTICALS For: Nov 01

Go back to Form 8-K RIGEL PHARMACEUTICALS For: Nov 01

Rigel Pharma (RIGL) Misses Q3 EPS by 1c

November 1, 2016 5:06 PM EDT

Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $3.97 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

... More